Development and validation of HPTLC method for estimation of tacrolimus in formulations

Drug Development and Industrial Pharmacy

Volumn 35, Issue 4, 2009, Pages 440-448

  Borhade, Vivek Baban ^a   Nair, Hema Ajit ^a   Hegde, Darshana Deepak ^a   Barhate, Chandrashekhar R ^a  

^a BOMBAY COLLEGE OF PHARMACY   (India)

Author keywords

Self microemulsifying formulations

Indexed keywords

ACETIC ACID; ACETONITRILE; AKOMED; ANISALDEHYDE; CAPRYOL; CREMOPHOR; DIETHYLENE GLYCOL MONOETHYL ETHER; EXCIPIENT; GELATIN; GLYCOFUROL; HYDROXYPROPYLMETHYLCELLULOSE; LACTOSE; LAUROGLYCOL; MACROGOL DERIVATIVE; MAGNESIUM STEARATE; MAISINE; MIGLYOL; MYRISTIC ACID ISOPROPYL ESTER; OCTANOIN; OLEIC ACID ETHYL ESTER; PANGRAF; PECEOL; SILICA GEL; SOLUTOL HS 15; SOLVENT; SOYBEAN OIL; SULFURIC ACID; SURFACTANT; TACROLIMUS; TOLUENE; UNCLASSIFIED DRUG; UNINDEXED DRUG; IMMUNOSUPPRESSIVE AGENT;

ACCURACY; ARTICLE; CALIBRATION; CONCENTRATION (PARAMETERS); DENSITOMETRY; DERIVATIZATION; DRUG FORMULATION; DRUG SOLUBILITY; EMULSION; HIGH PERFORMANCE THIN LAYER CHROMATOGRAPHY; MICROCAPSULE; PH; PRACTICE GUIDELINE; CHEMISTRY; DRUG STABILITY; PHARMACEUTICS; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY; SOLUBILITY; SOLUTION AND SOLUBILITY; THIN LAYER CHROMATOGRAPHY;

CALIBRATION; CAPSULES; CHEMISTRY, PHARMACEUTICAL; CHROMATOGRAPHY, THIN LAYER; DENSITOMETRY; DRUG STABILITY; IMMUNOSUPPRESSIVE AGENTS; PHARMACEUTICAL SOLUTIONS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; SOLUBILITY; TACROLIMUS; TECHNOLOGY, PHARMACEUTICAL;

EID: 65749094107     PISSN: 03639045     EISSN: 15205762     Source Type: Journal    
DOI: 10.1080/03639040802430594     Document Type: Article

References (19)

1. Akashi, T., Nefuji, T., Yoshida, M., & Hosoda, J. (1996). Quantitative determination of tautomeric FK506 by reversed-phase liquid chromatography. J. Pharm. Biomed. Anal., 14, 339-346.
2. Alak, A. M., Moy, S., & Menard, S. (1997). An HPLC/MS/MS assay for Tacrolimus in patient blood samples correlation with results of an ELISA assay. J. Pharm. Biomed. Anal., 16, 7-13.
3. Arima, H., Yunomae, K., Miyake, K., & Uekama, K. (2001). Comparative studies of the enhancing effects of cyclodextrins on solubility and oral bioavailability of Tacrolimus in rats. J. Pharm. Sci., 90, 690-701.
4. Beysens, A. J., Wijnen, R. M. H., & Beuman, G. H. (1991). Tacrolimus: Monitoring in plasma or in whole blood? Transplant. Proc., 23, 2745-2747.
5. Borhade, V. B. (2006). Study of specialized emulsions for drug delivery. Thesis, for the degree of master of pharmaceutical sciences, University of Mumbai, Mumbai
6. Borhade, V., Nair, H., & Hegde, D. (2008). Design and evaluation of selfmicroemulsifying drug delivery system (SMEDDS) of Tacrolimus. AAPS PharmSciTech., 9, 13-21.
7. Christine, E. A., & Susan, E. (2004). Clinical pharmacokinetics and pharmacodynamics of FK506 in solid organ transplantation. Clin. Pharmacokinet., 3, 623-653.
8. Deters, M., Kaever, V., & Kirchner, G. I. (2003). Liquid chromatography/mass spectrometry for therapeutic drug monitoring of immunosuppressants. Anal. Chim. Acta, 492, 133-145.
9. Dutta, S., Mezei, M., & Lee, T. D. (1998). Liposomal Tacrolimus and intestinal drug concentration. Transplant. Proc., 30, 2651-2652.
10. Kino, T., Hatanaka, H., Hashimoto, M., Nishiyama, M., Goto, T., Okuhara, M., & Kohsaka, M. (1987). FK506, a novel immunosuppressant isolated from a streptomyces I. Fermentation, isolation and physico-chemical and biological characteristics. J. Antibiot., 42, 1249-1255.
11. Koch, W. L. (1998). Erythromycin. In K. Florey (Ed.), Analytical profiles of drug substances (Vol. 8, pp. 159-177). London: Academic Press.
12. McAlister, V. C., Keshavamurthy, M., & Lee, T. D. G. (1999). Oral delivery of liposomal tacrolimus: Increased efficacy and reduced toxicity. Transplant. Proc., 31, 1110-1113.
13. Namiki, Y., Fujiwara, A., Kihara, N., Koda, S., & Hane, K. (1995). Factors affecting tautomeric phenomenon of a novel potent immunosuppressant (FK506) on the design for injectable formulation. Drug Dev. Ind. Pharm., 21, 809-822.
14. Shapiro, R. J. (1999). Tacrolimus in solid organ transplantation: An update. Transplant. Proc., 31, 2203-2205.
15. Spencer, C. M., Goa, K. L., & Gillis, J. C. (1997). Tacrolimus: An update of its pharmacology and clinical efficacy in the management of organ transplantation. Drugs, 54, 925-975.
16. Takada, K., Hashi, M., Yoshikawa, H., & Muranishi, S. (1990). Determination of a novel potent immunosuppreesant (FK-506) in rat serum and lymph by high-performance liquid chromatography with chemiluminescence detection. J. Chromatog., 530, 212-218.
17. Tamura, K., Kobayashi, M., & Rnhimoto, K. (1987). A highly sensitive method to assay Tacrolimus levels in plasma. Transplant. Proc., 19(Suppl. 6), 23-29.
18. Wallemacq, P. E., & Reding, R. (1993). FK-506, a novel immunosuppressant in organ transplantation: Clinical, biomedical, and analytical aspects. Clin. Chem., 39, 2219-2228.
19. Yamashita, K., Nakate, T., Okimoto, K., Ohike, A., Tokunaga, Y., Ibuki, R., Higaki, K., & Kimura, T. (2003). Establishment of new preparation method for solid dispersion formulation of tacrolimus. Int. J. Pharm., 267, 79-91.